Ketabi-Kiyanvash N - Search Results

1

Modulation of human BCRP (ABCG2) activity by anti-HIV drugs.

Weiss J, Rose J, Storch CH, Ketabi-Kiyanvash N, Sauer A, Haefeli WE, Efferth T. Weiss J, et al. Among authors: ketabi kiyanvash n. J Antimicrob Chemother. 2007 Feb;59(2):238-45. doi: 10.1093/jac/dkl474. Epub 2007 Jan 3. J Antimicrob Chemother. 2007. PMID: 17202245

2

P-glycoprotein modulation by the designer drugs methylenedioxymethamphetamine, methylenedioxyethylamphetamine and paramethoxyamphetamine.

Ketabi-Kiyanvash N, Weiss J, Haefeli WE, Mikus G. Ketabi-Kiyanvash N, et al. Addict Biol. 2003 Dec;8(4):413-8. doi: 10.1080/13556210310001646475. Addict Biol. 2003. PMID: 14690877

3

Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors.

Weiss J, Theile D, Ketabi-Kiyanvash N, Lindenmaier H, Haefeli WE. Weiss J, et al. Among authors: ketabi kiyanvash n. Drug Metab Dispos. 2007 Mar;35(3):340-4. doi: 10.1124/dmd.106.012765. Epub 2006 Dec 15. Drug Metab Dispos. 2007. PMID: 17172311

4

Comparison of the induction of P-glycoprotein activity by nucleotide, nucleoside, and non-nucleoside reverse transcriptase inhibitors.

Weiss J, Weis N, Ketabi-Kiyanvash N, Storch CH, Haefeli WE. Weiss J, et al. Among authors: ketabi kiyanvash n. Eur J Pharmacol. 2008 Jan 28;579(1-3):104-9. doi: 10.1016/j.ejphar.2007.11.007. Epub 2007 Nov 13. Eur J Pharmacol. 2008. PMID: 18037401

5

Induction of multiple drug transporters by efavirenz.

Weiss J, Herzog M, König S, Storch CH, Ketabi-Kiyanvash N, Haefeli WE. Weiss J, et al. Among authors: ketabi kiyanvash n. J Pharmacol Sci. 2009 Feb;109(2):242-50. doi: 10.1254/jphs.08209fp. J Pharmacol Sci. 2009. PMID: 19234366 Free article.

6

Inhibition of P-glycoprotein by newer antidepressants.

Weiss J, Dormann SM, Martin-Facklam M, Kerpen CJ, Ketabi-Kiyanvash N, Haefeli WE. Weiss J, et al. Among authors: ketabi kiyanvash n. J Pharmacol Exp Ther. 2003 Apr;305(1):197-204. doi: 10.1124/jpet.102.046532. J Pharmacol Exp Ther. 2003. PMID: 12649369

7

NKIM-6, a new immortalized human brain capillary endothelial cell line with conserved endothelial characteristics.

Ketabi-Kiyanvash N, Herold-Mende C, Kashfi F, Caldeira S, Tommasino M, Haefeli WE, Weiss J. Ketabi-Kiyanvash N, et al. Cell Tissue Res. 2007 Apr;328(1):19-29. doi: 10.1007/s00441-006-0348-4. Epub 2006 Dec 19. Cell Tissue Res. 2007. PMID: 17180596

8

Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma.

Theile D, Ketabi-Kiyanvash N, Herold-Mende C, Dyckhoff G, Efferth T, Bertholet V, Haefeli WE, Weiss J. Theile D, et al. Among authors: ketabi kiyanvash n. Head Neck. 2011 Jul;33(7):959-68. doi: 10.1002/hed.21559. Epub 2010 Aug 24. Head Neck. 2011. PMID: 20737486

9

Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?

Martin-Facklam M, Rengelshausen J, Tayrouz Y, Ketabi-Kiyanvash N, Lindenmaier H, Schneider V, Bergk V, Haefeli WE. Martin-Facklam M, et al. Among authors: ketabi kiyanvash n. Eur J Clin Pharmacol. 2005 Jan;60(11):807-11. doi: 10.1007/s00228-004-0852-y. Epub 2004 Dec 14. Eur J Clin Pharmacol. 2005. PMID: 15599503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters